Difference between revisions of "Clinical Guidelines FHIR IG Proposal"

From HL7Wiki
Jump to navigation Jump to search
(Created page with "{{subst::Template:FHIR IG Proposal}}")
 
 
(3 intermediate revisions by one other user not shown)
Line 3: Line 3:
 
<div style="float: left;">[[Image:OpenHotTopic.GIF|35px| ]]</div>
 
<div style="float: left;">[[Image:OpenHotTopic.GIF|35px| ]]</div>
 
<div style="background:#F0F0F0">
 
<div style="background:#F0F0F0">
This page documents a [[:category:Pending FHIR IG Proposal|Pending]] [[:category:FHIR IG Proposal|FHIR IG Proposal]]
+
This page documents a [[:category:Approved  FHIR IG Proposal|Approved]] [[:category:FHIR IG Proposal|FHIR IG Proposal]]
 
</div>
 
</div>
 
</div>
 
</div>
 
[[Category:FHIR IG Proposal]]
 
[[Category:FHIR IG Proposal]]
[[Category:Pending FHIR IG Proposal]]
+
[[Category:Approved  FHIR IG Proposal]]
  
 
+
=Recommendation of Clinical Practice Guideline Recommendations in FHIR=
<!-- For additional guidance on considerations for resource creation, refer to [[FHIR IG Considerations]] -->
 
 
 
 
 
=PutProposedIGNameHere=
 
 
 
<!-- Resource names should meet the following characteristics:
 
* Title Case
 
* U.S. English
 
* Domain-friendly
 
* Short
 
* Clear
 
* Unique
 
* Avoid non-universal abbreviations (e.g. URL would be ok)
 
* Be consistent with other similar IGs
 
-->
 
  
 
==Owning work group name==
 
==Owning work group name==
  
 
<!-- The name of the committee that is proposed to have responsibility for developing and maintaining the IG. -->
 
<!-- The name of the committee that is proposed to have responsibility for developing and maintaining the IG. -->
[[YourWorkGroupName]]
+
[[Clinical Decision Support]]
  
 
==Committee Approval Date:==
 
==Committee Approval Date:==
<i>Please enter the date that the committee approved this IGproposal</i>
+
PSS: 2019-01-15
 +
IG Proposal: 2019-07-10 (https://confluence.hl7.org/display/CDS/2019-07-10+Meeting+Agenda)
  
 
==Publishing Lead==
 
==Publishing Lead==
  
<!--Name and email of the primary contact for the FMG with respect to publishing for this IG?-->
+
Bryn Rhodes
 +
bryn@databaseconsultinggroup.com
  
 
==Contributing or Reviewing Work Groups==
 
==Contributing or Reviewing Work Groups==
  
<!-- Additional work groups that may have an interest in contributing to, or reviewing  the content of the IG (optional) -->
+
* Clinical Quality Information (Co-Sponsor, approved 2019-01-16)
* Work Group Name
+
* Patient Care (Co-Sponsor, approved 2019-02-18)
* or link
+
* Public Health (Interested Party, contributing example content)
* or "None"
 
  
 
==FHIR Development Project Insight ID==
 
==FHIR Development Project Insight ID==
  
<!-- Please specify the id of your work group’s PSS for doing FHIR work that covers the development and maintenance of this IG.  (If submitted but not yet approved, just write “pending”.) The link to the PSS template can be found here: http://gforge.hl7.org/gf/download/docmanfileversion/6832/9398/HL7FHIR_DSTUballotPSS-20120529.doc -->
+
1505
  
 
==Scope of coverage==
 
==Scope of coverage==
  
<!-- Define the full scope of coverage for the IG.  **(NOT the project - Do NOT copy from the PSS)**  The scope must be clearly delineated such that it does not overlap with any other existing or expected HL7 Int'l-maintained IG.  The scope will be used to govern "what is the set of potential applications to consider when evaluating what elements are 'core' – i.e. in the 80%".  Essentially, set the boundaries that would determine whether new content brought to HL7 should fall within the scope of your IG or somewhere else. This should be 1 paragraph max.
+
This implementation guide is intended to support expression of computable clinical guidelines across clinical domains, and in any locale. Of particular interest is ensuring support for Low and Middle Income Countries (LMIC) to enable organizations like the CDC and WHO to produce computable versions of their paper guidelines.  
 
 
Scope should consider numerous aspects of breadth of scope, including:
 
* Subject: Human vs. non-human vs. non-patient (e.g. lab bench medicine)
 
* Disciplines: Environmental Health, Palliative, Respiratory, Psychology, Maternity, Clinical Research
 
* Delivery environment (Community, Geriatric, Home care, Emergency, Inpatient, Intensive, Neonatal, Pediatric, Primary)
 
* Locale: Country, region
 
-->
 
  
 
==Content location==
 
==Content location==
  
<!-- What is the path within the HL7 github repository (i.e. https://github.com/HL7/xxx) or what is the Simplifier project name? -->
+
http://github.org/HL7/cqf-recommendations
  
  
 
==Proposed IG realm and code==
 
==Proposed IG realm and code==
  
<!-- What is the realm code (2-character country code or 'uv') and IG code to use for the path when the IG is published under http://hl7.org/fhir?  E.g. us/ccda -->
+
uv/cpg
  
 
==Maintenance Plan==
 
==Maintenance Plan==
  
<!-- What commitment does the WG have to maintaining this IG as the FHIR core specification continues to evolve - particularly if the initial project sponsors are no longer providing resources.  I.e. Who will be maintaining this IG content 5 years after it's published? -->
+
Guideline developers participating in the project (such as CDC and WHO) are interested in developing content IGs that are based on this IG and so have an interest in maintaining it.
  
 
==Short Description==
 
==Short Description==
  
<!-- 1-2 sentences describing the purpose/scope of the IG for inclusion in the registry- this is the sentence that will be used here: http://www.fhir.org/guides/registry.  This must describe the IG from the perspective of an implementer scanning a registry, it should not talk about the project and should NOT be copied from the PSS. -->
+
This implementation guide is a multi-stakeholder effort to use FHIR resources to build shareable and computable representations of the content of clinical care guidelines. The guide focuses on common patterns in clinical guidelines, establishing profiles, conformance requirements, and guidance for the patient-independent, as well as analogous patterns for the patient-specific representation of guideline recommendations.
 
 
  
 
==Long Description==
 
==Long Description==
  
<!-- 1-2 paragraphs describing the purpose/scope of the IG in more detail for inclusion in the version history - this is content that will be used in your IG's equivalent of this: http://www.hl7.org/fhir/us/core/history.cfml.  Again, this must describe the IG from the perspective of an implementer scanning a registry, it should not talk about the project and should NOT be copied from the PSS. -->
+
The process of guideline implementation is a significant challenge that is currently complicated by the lack of computable guideline content. Health systems and vendors implement evidence-based guidance, but almost always independently, leading to signficant duplicate effort, as well as inconsistent implementation. This implementation guide will build on experience from multiple guideline representation projects to establish patterns and practices that support development and implementation of shareable computable guideline recommendations.
  
 +
The specification combines experience gained from multiple guideline representation projects, including Opioid Prescribing Support, Chronic Kidney Disease Management, Antenatal Care, HIV/HBV Screening, Prevention, and Treatment, and Immunization Decision Support.
  
 
==Involved parties==
 
==Involved parties==
  
<!-- 1 paragraph describing who is sponsoring or involved in creating the IG **for inclusion in the version history**.  Don't copy from the PSS - think about the specific language you want to appear in the registry. -->
+
Centers for Disease Control
 +
World Health Organization
 +
IHE Quality Reporting and Public Health Workgroup (Coordinated with the CCG and DCP profiles)
  
  
 
==Expected implementations==
 
==Expected implementations==
  
<!--Provide named implementations if possible - ideally provide multiple independent implementations. -->
+
Allscripts
 +
OpenMRS/OpenSRP
 +
DHIS2
  
 
==Content sources==
 
==Content sources==
  
<!-- List all of the specifications (beyond those in the "standard" (FHIR_Design_Requirements_Sources) list of source specifications) that you’re planning to consult
+
Previous work on computable guideline representation presented to the AeHIN
 
+
Opioid Prescribing Support implementation guide
Are there any source specifications that you wish to consult but are concerned about access to or expertise to consider? -->
+
Quality Measure implementation guide
 +
Pilot work from the Clinical Quality Framework (including radiology, chlamydia screening, and zika virus)
  
 
==Example Scenarios==
 
==Example Scenarios==
  
<!-- Provide a listing of the types of scenarios to be represented in the examples produced for this IG.  They should demonstrate the full scope of the IG and allow exercising of the IG's capabilities (all profiles, different types of applications, etc.) -->
+
CDC Opioid Prescribing Support Guideline
 +
WHO Antenatal Care Guideline
 +
Chronic Disease Management - Chronic Kidney Disease
 +
Hepatitis B Screening, Immunization, and Follow-up
 +
Immunization Recommendations
  
 
==IG Relationships==
 
==IG Relationships==
  
<!-- Are there any IGs this resource depends on or that depend on this IG? -->
+
This IG will provide profiles, guidance, and conformance requirements to enable "content" IGs such as the CDC Opioid Prescribing Guideline Implementation Guide.
 +
 
 +
This IG is also complementary to the Quality Measure IG, supporting the decision support aspects of quality improvement, while that IG focuses on the quality measurement aspects.
 +
 
 +
This IG will also be coordinated with the IHE Computable Care Guidelines (CCG) profile (which will focus on testability of computable guideline content) and the Dynamic Care Planning (DCP) profile (which focuses on care planning for patients).
  
 
==Timelines==
 
==Timelines==
  
<!-- Indicate the target date for having the IGcomplete from a committee perspective and ready for vetting and voting -->
+
Initial content draft is already in place, planning to have everything finalized by July 21st for review by the sponsoring work groups.
  
 
==When IG Proposal Is Complete==
 
==When IG Proposal Is Complete==

Latest revision as of 21:33, 17 July 2019

Recommendation of Clinical Practice Guideline Recommendations in FHIR

Owning work group name

Clinical Decision Support

Committee Approval Date:

PSS: 2019-01-15 IG Proposal: 2019-07-10 (https://confluence.hl7.org/display/CDS/2019-07-10+Meeting+Agenda)

Publishing Lead

Bryn Rhodes bryn@databaseconsultinggroup.com

Contributing or Reviewing Work Groups

  • Clinical Quality Information (Co-Sponsor, approved 2019-01-16)
  • Patient Care (Co-Sponsor, approved 2019-02-18)
  • Public Health (Interested Party, contributing example content)

FHIR Development Project Insight ID

1505

Scope of coverage

This implementation guide is intended to support expression of computable clinical guidelines across clinical domains, and in any locale. Of particular interest is ensuring support for Low and Middle Income Countries (LMIC) to enable organizations like the CDC and WHO to produce computable versions of their paper guidelines.

Content location

http://github.org/HL7/cqf-recommendations


Proposed IG realm and code

uv/cpg

Maintenance Plan

Guideline developers participating in the project (such as CDC and WHO) are interested in developing content IGs that are based on this IG and so have an interest in maintaining it.

Short Description

This implementation guide is a multi-stakeholder effort to use FHIR resources to build shareable and computable representations of the content of clinical care guidelines. The guide focuses on common patterns in clinical guidelines, establishing profiles, conformance requirements, and guidance for the patient-independent, as well as analogous patterns for the patient-specific representation of guideline recommendations.

Long Description

The process of guideline implementation is a significant challenge that is currently complicated by the lack of computable guideline content. Health systems and vendors implement evidence-based guidance, but almost always independently, leading to signficant duplicate effort, as well as inconsistent implementation. This implementation guide will build on experience from multiple guideline representation projects to establish patterns and practices that support development and implementation of shareable computable guideline recommendations.

The specification combines experience gained from multiple guideline representation projects, including Opioid Prescribing Support, Chronic Kidney Disease Management, Antenatal Care, HIV/HBV Screening, Prevention, and Treatment, and Immunization Decision Support.

Involved parties

Centers for Disease Control World Health Organization IHE Quality Reporting and Public Health Workgroup (Coordinated with the CCG and DCP profiles)


Expected implementations

Allscripts OpenMRS/OpenSRP DHIS2

Content sources

Previous work on computable guideline representation presented to the AeHIN Opioid Prescribing Support implementation guide Quality Measure implementation guide Pilot work from the Clinical Quality Framework (including radiology, chlamydia screening, and zika virus)

Example Scenarios

CDC Opioid Prescribing Support Guideline WHO Antenatal Care Guideline Chronic Disease Management - Chronic Kidney Disease Hepatitis B Screening, Immunization, and Follow-up Immunization Recommendations

IG Relationships

This IG will provide profiles, guidance, and conformance requirements to enable "content" IGs such as the CDC Opioid Prescribing Guideline Implementation Guide.

This IG is also complementary to the Quality Measure IG, supporting the decision support aspects of quality improvement, while that IG focuses on the quality measurement aspects.

This IG will also be coordinated with the IHE Computable Care Guidelines (CCG) profile (which will focus on testability of computable guideline content) and the Dynamic Care Planning (DCP) profile (which focuses on care planning for patients).

Timelines

Initial content draft is already in place, planning to have everything finalized by July 21st for review by the sponsoring work groups.

When IG Proposal Is Complete

When you have completed your proposal, please send an email to FMGcontact@HL7.org

FMG Notes